Teaching the basics of nuclear receptor action: A simple laboratory exercise using the yeast two-hybrid method

American Journal of Pharmaceutical Education

Volumn 69, Issue 2, 2005, Pages 176-183

  Mäkinen, Janne ^a   Petersen, Silvia ^b   Honkakoski, Paavo ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Laboratory experiment; Ligand; Nuclear receptor; Teaching; Yeast two hybrid

Indexed keywords

EID: 27644453118     PISSN: 00029459     EISSN: None     Source Type: Journal    
DOI: 10.5688/aj690226     Document Type: Article

References (28)

1. Aranda A, Pascual A. Nuclear hormone receptors and gene expression. Physiol Rev. 2001;81:1269-304.
2. Honkakoski P. Nuclear receptors CAR and PXR in metabolism and elimination of drugs. Curr Pharmacogenomics. 2003;1:75-85.
3. Bourguet W, Germain P, Gronemeyer H. Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications. Trends Pharmacol Sci. 2000;21:381-8.
4. Emery JG, Ohlstein EH, Jaye M. Therapeutic modulation of transcription factor activity. Trends Pharmacol Sci. 2001;22:233-40.
5. McKenna NJ, Lanz RB, O'Malley BW. Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev. 1999;20:321-44.
6. Willson TM, Kliewer SA. PXR, CAR and drug metabolism. Nature Rev Drug Discovery. 2002;1:259-66.
7. Xie W, Uppal H, Saini SPS, Mu Y, Little JM, Radominska-Pandya A, Zemaitis MA. Orphan nuclear receptor-mediated xenobiotic regulation in drug metabolism. Drug Discovery Today. 2004;9:442-9.
8. Maglich JM, Watson J, McMillen PJ, Goodwin B, Willson TM, Moore JT. The nuclear receptor CAR is a regulator of thyroid hormone metabolism during caloric restriction. J Biol Chem. 2004; 279:19832-8.
9. Rodrigues AD, Lin JH. Screening of drug candidates for their drug-drug interaction potential. Curr Opinions Chem Biol. 2001;5:396-401.
10. Forman BM, Tzameli I, Choi HS, Chen J, Simha D, Seol W, Evans RM, Moore DD. Androstane metabolites bind to and deactivate the nuclear receptor CAR-β. Nature. 1998;395:612-5.
11. Jyrkkärinne J, Mäkinen J, Gynther J, Savolainen H, Poso A, Honkakoski, P. Molecular determinants of steroid inhibition for constitutive androstane receptor CAR. J Med Chem. 2003;46:4687-95.
12. Toby GG, Golemis EA. Using the yeast interaction trap and other two-hybrid-based approaches to study protein-protein interactions. Methods. 2001;24:201-17.
13. Clontech - Yeast Protocols Handbook. Available at: http://www. bdbiosciences.com/clontech/techinfo/manuals/PDF/PT3024-1.pdf. Accessed December 13, 2003.
14. Nishihara T, Nishikawa JI, Kanayama T, Dakeyama F, Saito K, Imagawa M, Takatori S, Kitagawa Y, Hori S, Utsumi, H. Estrogenic activities of 517 chemicals by yeast two-hybrid assay. J Health Sci. 2000;46:282-98.
15. Sambrook J, Russell DW, eds. Molecular Cloning. 3rd ed. 2001. CSHL Press, NY.
16. Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell. 1998;92:829-39.
17. NucleaRDB. An Information System for Nuclear Receptors. Available at http://receptors.ucsf.edu/NR/. Accessed September 15, 2004.
18. Li B, Fields S. Identification of mutations in p53 that affect its binding to SV40 large T antigen by using the yeast two-hybrid system. Fed Am Soc Exp Bio J.1993;7:957-63.
19. Mäkinen J, Jyrkkärinne J, Viitala P, Chung H, Pelkonen O, Honkakoski P. Dual action of estrogens on the mouse constitutive androstane receptor. Biochem J. 2003;376:465-72.
20. Mäkinen J, Frank C, Jyrkkärinne J, Gynther J, Carlberg C, Honkakoski P. Modulation of mouse and human phenobarbital-responsive enhancer module by nuclear receptors. Mol Pharmacol. 2002;62:366-78.
21. Jyrkkärinne J, Windshügel B, Mäkinen J, Ylisirniö M, Peräkylä M, Poso A, Sippl W, Honkakoski P. Amino acids important for ligand specificity of the human constitutive androstane receptor. J Biol Chem 2005;280:5960-71.
22. Matsushita A, Misawa H, Andoh S, Natsume H, Nishiyama K, Sasaki S, Nakamura H. Very strong correlation between dominant negative activities of mutant thyroid hormone receptors and their binding avidity for corepressor SMRT. J Endocrinol. 2000;167:493-503.
23. Kraichely DM, Sun J, Katzenellenbogen JA, Katzenellenbogen BS. Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-α and estrogen receptor-β: correlations with biological character and distinct differences among SRC coactivator family members. Endocrinology. 2000;141:3534-45.
24. http://www.bmb.leeds.ac.uk/staff/pam/HYBRID.HTM. Accessed April 26, 2004.
25. Sobhanifar S. Yeast two-hybrid assay: a fishing tale. Bio Teach J. 2003;1:81-87.
26. Odom DP, Grossel MJ. Using the two-hybrid screen in the classroom laboratory. Cell Biol Educ. 2002;1:43-62
27. Carvalho F, Gillespie ME. Bringing proteomics into the lab. Biochem Mol Biol Educ. 2003;31:46-51.
28. MSc Medical Science in Clinical Pharmacology. Available at: http://www.medther.gla.ac.uk/dept/clinphar.html Accessed on April 27, 2004.